AI Bio 소식
[ Medkoo 공식 대리점] 0990CL(562975)
- AI바이오허브 오래 전 2025.07.02 21:30 제품소개
-
79
0
Name: 0990CL
MedKoo Cat# : 562975
CAS# : 511514-03-7
Exact Mass: 343.1797
Molecular Weight: 343.43
Elemental Analysis: C, 73.44; H, 6.16; N, 20.39
Related CAS #;No Data
Synonym:0990CL; 0990-CL; 0990 CL;
IUPAC/Chemical Name:(4-Phenyl-quinazolin-2-yl)-(4,6,6-trimethyl-1,6-dihydro-pyrimidin-2-yl)-amine
InChi Key:DXICUHJLOMNKOU-UHFFFAOYSA-N
InChi Code:InChI=1S/C21H21N5/c1-14-13-21(2,3)26-20(22-14)25-19-23-17-12-8-7-11-16(17)18(24-19)15-9-5-4-6-10-15/h4-13H,1-3H3,(H2,22,23,24,25,26)
SMILES Code:CC1(C)C=C(C)N=C(NC2=NC(C3=CC=CC=C3)=C4C=CC=CC4=N2)N1
Appearance:Solid powder
Purity:>98% (or refer to the Certificate of Analysis)
Shipping Condition:Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition:Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility:Soluble in DMSO
Shelf Life:>2 years if stored properly
Drug Formulation:This drug may be formulated in DMSO
Stock Solution Storage:0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code:2934.99.9001
Biological target:0990CL is a specific heterotrimeric Gαi subunit inhibitor by direct interaction with Gαi.
In vitro activity:TBD
In vivo activity:TBD
Reference:
Appleton KM, Bigham KJ, Lindsey CC, Hazard S, Lirjoni J, Parnham S, Hennig M, Peterson YK. Development of inhibitors of heterotrimeric Gαi subunits. Bioorg Med Chem. 2014 Jul 1;22(13):3423-34. doi: 10.1016/j.bmc.2014.04.035. Epub 2014 Apr 26. PMID: 24818958; PMCID: PMC4103618.
견적 문의: aibiohub@aibiohub.co.kr 홈페이지: www.aibiohub.co.kr
견적 문의: https://aibiohub.co.kr/estimate/write
- 이전글[ Scripps Laboratories 공식 대리점]Creatine Kinase MB, Recombinant(90673-0100)2025.07.03
- 다음글[ Lonza 공식 대리점]Cell & Gene2025.07.02
댓글목록
등록된 댓글이 없습니다.
